New Prevention Technologies Workshop Module 2: NPTs in context WWW.ICAD-CISD.COM.

Slides:



Advertisements
Similar presentations
HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS.
Advertisements

What does sexual & reproductive health have to do with clinical trials? Providing contraception & reproductive health care helps.
Children and young people, injecting and HIV Under-18 and overlooked Young People and Injecting Drug Use: Overcoming barriers to HIV Prevention and Harmonizing.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
STDs Valerie Robinson D.O.. Prevention Abstinence Risk reduction Vaccines Male or female condoms Cervical diaphragm might protect against cervical GC,
Dr. Carol Odula (Obs./Gyn.) May 7 th 2013 Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection.
From “What If” to “What Now” Perspectives on ARVs and the Future of Treatment and Prevention Mitchell Warren Executive Director, AVAC IAS 2011, Rome.
Microbicides Envision a product that could save lives Your name here
What is it? How may it help women? PrEP. What is PrEP? How would it work? What do we know about it? When will we know more? What could it mean for women?
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Hadiyah Charles, Community HIV/AIDS Mobilization Project Naina Khanna, WORLD/U.S. Positive Women’s Network HIV Research Catalyst Forum April 21, 2010.
© Aahung 2004 Millennium Development Goals Expanding the Agenda:
THE EPIDEMIOLOGY OF HIV/AIDS. HIV/AIDS – USA 2009 Living with HIV/AIDS = 1.2 million Incidence = 56,000/year MSM = 53% Heterosexuals = 31% IDUs.
Lessons learned from Nairobi, and experiences from Serbia Mr.sci.prim.dr Dragan Ilić epidemiologist Република Србија МИНИСТАРСТВО ЗДРАВЉА 1.
European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.
How well are we doing in preventing HIV and how can we do better?
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
Incorporating HIV Prevention into the Medical Care of Persons Living with HIV Ask ∙ Screen ∙ Intervene Developed by: The National Network of STD/HIV Prevention.
HIV and Reproductive Health? William Stones. Questions What is reproductive health? Is HIV best approached as a RH topic? What are the pros and cons of.
Epidemiology of HIV and Access to Prevention services, Tanzania Joint Biennial HIV National Response Review Stakeholders meeting. November, 2014 Blue Pearl.
Rectal Microbicides: The Basics Date, Location Your name, Your affiliation.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.
Rectal Microbicides: The Basics Date, Location Your Name, Organization.
Steven Shoptaw, PhD UCLA Department of Family Medicine Center for Behavioral and Addiction Medicine A DRAFT PACKAGE OF INTERVENTIONS.
Preventive Measures on HIV/AIDS Because the most common ways HIV is transmitted is through anal or viginal sex or sharing drug injection equipment with.
Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.
Introduction to HIV New Prevention Technologies (NPTs)
Microbicides: New Hope for Prevention of HIV and other STIs
LIMPOPO PROVINCIAL MEN’S SECTORS/BROTHERS FOR LIFE PRESENTED BY: RAPAKWANA JOHANNAH MANAGER:GAAP in HIV & AIDS & STIs Directorate DEPT OF HEALTH AND SOCIAL.
Microbicides: Who, what, where, when and how Rebekah Webb Global Campaign for Microbicides © Salam Dahbor,
Cindra Feuer and Marc-André LeBlanc HRCF, 21 April 2010 ARV-based Prevention.
October 8, 2010 USAID Mini-University Clancy Broxton, MA, MPH Most At Risk Populations Advisor USAID Office of HIV/AIDS HIV Prevention for Most At- Risk.
Public Access to Health Information. HIV/AIDS Module.
HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.
Biomedical Approaches to HIV Prevention HIV Research Catalyst Forum April 21, 2010, Baltimore, MD Monica S. Ruiz, PhD, MPH George Washington University.
The HIV virus. The overwhelming majority of people with HIV live in low- and middle-income countries. Sub- Saharan Africa accounts for two-thirds.
Microbicides: Science, research, and overview of the field Dr Kamini Walia, Indian Council of Medical Research, New Delhi Bindiya Patel, Global Campaign.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
Resource Needs Model Rachel Sanders October 28 th, 2010.
HIV/AIDS IN PERU. Map General statistics Population million Life expectancy: Male: years Female: 75.6 years GNI billion Literacy.
Rectal Microbicides: New Hope for HIV and STD Prevention.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Session: Voluntary Medical Male Circumcision (VMMC)
National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007.
Mobilizing for RH/HIV Integration Addis Ababa, Ethiopia Session on Technical Issues and Intersections Wednesday, February 26, 2008.
HIV Prevention : Why we need more options for women Wanjiku Kamau Consultant: International AIDS Vaccine Initiative Consultant: International Partnership.
Partnering to Promote Female-controlled HIV Prevention Methods Matthews J, Becker J, Massey C, Jacobsen J, Patel B Ibis Reproductive Health, International.
What is HIV? HIV is a virus that takes over certain immune system cells to make many copies of itself. HIV causes slow but constant damage to the immune.
INVESTING TO END THE AIDS EPIDEMIC: A NEW ERA FOR HIV RESEARCH & DEVELOPMENT HIV VACCINES WORKING GROUP & MICROBICIDES RESOURCE TRACKING E. Donaldson 1,
Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.
Challenges in addressing community understanding of rectal microbicides I am Obiajulu Augustina Amuamuziam and I work for NHVMAS in Lagos, Nigeria. Currently.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) HIV Prevention Training Package Session 2: Combination.
Pagare Maya & Yewale Sakhu. 1. We aimed at desiging on all purpose 9 th and 10 th std. students give the information of aids. Create the scientific attitude.
HIV/AIDS IN AFRICA- "The Orphaned Continent"
A pill to prevent HIV? For women??
New ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
ARV-Based Prevention What it means for women Your name here
The Uganda Country Presentation EAC Think Tank on HIV Prevention 24th to 26 th February 2009 Laico Regency Hotel, Nairobi, Kenya Republic of UgandaUganda.
International Aid Towards HIV/AIDs in sub-Saharan Africa Ally H. Van Valen.
BRADFORD BRIGGS & NIKE JACKSON. BRADFORD BRIGGS Prevention Toolbox.
HIV Epidemic in Malaysia. HIV BY AGE GROUPS - MALAYSIA.
IAS Satellite Session 25th July 2017 Daniel Were, PhD
Number of people receiving antiretroviral therapy in
Myanmar Last Update: November 2014.
Mission: To reduce morbidity associated with the prevalence of TB and HIV among at-risk drug users and their contacts.
Microbicides: Who, what, where, when and how
HIV.
Presentation transcript:

New Prevention Technologies Workshop Module 2: NPTs in context

National Policy HIV prevention (including NPTs) is a core component of the following national policy frameworks:  Leading Together: Canada Takes Action on HIV/AIDS  Federal Initiative to Address HIV/AIDS in Canada  Canadian HIV Vaccines Initiative  Canadian HIV Vaccines Plan  Canadian Microbicides Action Plan

Percentage of at-risk people with access to HIV prevention 0 Rose to 45% recently <20% Sex workers with access to behaviour change programmes 11% HIV+ pregnant women with access to PMTCT 10–12% Adults in Africa accessing HIV testing 9% Men who have sex with men with access to appropriate behaviour change programmes 9% Sexually active people with access to male condoms 8% Injection drug users with access to harm reduction programmes

Imagine a full spectrum of interventions  Rights-focused behaviour change  Voluntary counselling & testing  Sexually transmitted infection screening and treatment  Male medical circumcision  Preventative vaccines  Pre-exposure prophylaxis (PrEP) Prior to exposure Point of transmission After infection  Male & Female condoms and lubricant  Treatment to prevent vertical transmission (PMTCT)  Clean injecting equipment  Post-exposure prophylaxis (PEP)  Vaginal & rectal microbicides  Cervical barriers  Antiretroviral treatment  Treatment for opportunistic infections  Basic care/nutrition  Prevention for positives  Education and rights- focused behaviour change  Therapeutic vaccines  Functional cure

PrEP Clean injecting equipment Cervical barriers: vaginal diaphragms PMTCT Vaccines Voluntary counselling and testing HIV Prevention Microbicides Male and female condoms Male circumcision PEP

Protection in Primary Partnerships: Difficult to Achieve  People generally are willing to use condoms with new partners, or during casual or commercial sex  But once “trust” enters the equation the condom comes off  Sex with a primary partner is the biggest source of HIV infection among women globally

Why condoms are not enough

ABCs…not so simple ABC—abstinence, be faithful, use a condom  Abstinence – not relevant in the context of primary sexual partnerships, and unrealistic for most people  Be Faithful – partner’s fidelity is outside of an individual’s control  Use Condoms - not relevant in the context of primary sexual partnerships, doesn’t allow conception, under control of male partner

Partial efficacy

Condoms and NPTs

DISCUSSION QUESTION What is higher priority:  Advocating for improved access to existing prevention interventions?  Advocating for more prevention options?  Both? WHY?